{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:00:27Z","timestamp":1776214827976,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ygyno.2015.03.047","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T07:27:50Z","timestamp":1428305270000},"page":"485-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Patterns and utility of routine surveillance in high grade endometrial cancer"],"prefix":"10.1016","volume":"137","clinical-trial-number":[{"clinical-trial-number":"nct00916708","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jessica","family":"Hunn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meaghan E.","family":"Tenney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana I.","family":"Tergas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin A.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Watkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Hurteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo C.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nita K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Diane","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ygyno.2015.03.047_bb0005","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/IGC.0b013e31821bd473","article-title":"Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Societe Francaise d'Oncologie Gynecologique","volume":"21","author":"Querleu","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2015.03.047_bb0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical\u2013pathological risk factors and outcome in clinical Stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2015.03.047_bb0015","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1048-891X.2004.014532.x","article-title":"The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients","volume":"14","author":"Tjalma","year":"2004","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2015.03.047_bb0020","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjc.6603012","article-title":"Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers","volume":"94","author":"Hamilton","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2015.03.047_bb0025","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2006.02.011","article-title":"Follow-up after primary therapy for endometrial cancer: a systematic review","volume":"101","author":"Fung-Kee-Fung","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.03.047_bb0030","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"9213","key":"10.1016\/j.ygyno.2015.03.047_bb0035","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with Stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ygyno.2015.03.047_bb0040","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in Stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.03.047_bb0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00006250-197907000-00020","article-title":"A prospective trail comparing hysterectomy, hysterectomy plus vaginal radium, and uterine radium plus hysterectomy in Stage I endometrial carcinoma","volume":"54","author":"Piver","year":"1979","journal-title":"Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.ygyno.2015.03.047_bb0050","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0959-8049(01)00066-1","article-title":"Value and cost evaluation of routine follow-up for patients with clinical Stage I\/II endometrial cancer","volume":"37","author":"Morice","year":"2001","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2015.03.047_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/01.AOG.0000194206.38105.c8","article-title":"Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?","volume":"107","author":"Cooper","year":"2006","journal-title":"Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.ygyno.2015.03.047_bb0060","first-page":"879","article-title":"Costs and benefits of routine follow-up after curative treatment for endometrial cancer","volume":"157","author":"Agboola","year":"1997","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.ygyno.2015.03.047_bb0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ygyno.2011.07.014","article-title":"Recurrence patterns and surveillance for patients with early stage endometrial cancer","volume":"123","author":"Salani","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.03.047_bb0070","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ygyno.2006.05.013","article-title":"Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance","volume":"103","author":"Bristow","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.03.047_bb0075","author":"NCCN Guidelines Version 2.2015"},{"issue":"2","key":"10.1016\/j.ygyno.2015.03.047_bb0080","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ygyno.2012.07.105","article-title":"Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure","volume":"127","author":"Tergas","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.03.047_bb0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2011.07.030","article-title":"Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer\u2014a clinical and pathological evaluation","volume":"124","author":"Voss","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.03.047_bb0090","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ygyno.2013.03.011","article-title":"Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas","volume":"129","author":"Ayeni","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2015.03.047_bb0095","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":"Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations","volume":"204","author":"Salani","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.03.047_bb0100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1479-828X.1997.tb02229.x","article-title":"Vaginal vault cytology in the routine follow-up of patients treated for endometrial carcinoma: is it useful?","volume":"37","author":"Ng","year":"1997","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"issue":"5","key":"10.1016\/j.ygyno.2015.03.047_bb0105","first-page":"692","article-title":"Computed tomography in endometrial carcinoma","volume":"95","author":"Connor","year":"2000","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2015.03.047_bb0110","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2010.08.013","article-title":"Predictive factors for prolonged survival in recurrent endometrial carcinoma: implications for follow-up protocol","volume":"119","author":"Otsuka","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"21","key":"10.1016\/j.ygyno.2015.03.047_bb0115","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1200\/JCO.2012.42.6189","article-title":"Who benefits from surveillance imaging?","volume":"30","author":"Armitage","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"21","key":"10.1016\/j.ygyno.2015.03.047_bb0120","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1200\/JCO.2011.40.7841","article-title":"Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group","volume":"30","author":"Voss","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"7077","key":"10.1016\/j.ygyno.2015.03.047_bb0125","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/bmj.314.7077.343a","article-title":"Followup policy after treatment for Hodgkin's disease: too many clinic visits and routine tests? A review of hospital records","volume":"314","author":"Radford","year":"1997","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ygyno.2015.03.047_bb0130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.6004\/jnccn.2011.0048","article-title":"Role of routine imaging in lymphoma","volume":"9","author":"Wagner-Johnston","year":"2011","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"6","key":"10.1016\/j.ygyno.2015.03.047_bb0135","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/annonc\/mdl049","article-title":"Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population","volume":"17","author":"Liedtke","year":"2006","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2015.03.047_bb0140","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3324\/haematol.2009.020115","article-title":"Surveillance investigations after high-dose therapy with stem cell rescue for recurrent follicular lymphoma have no impact on management","volume":"95","author":"Gerlinger","year":"2010","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.ygyno.2015.03.047_bb0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/gyno.1995.0012","article-title":"Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme","volume":"59","author":"Reddoch","year":"1995","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.03.047_bb0150","first-page":"12","article-title":"Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma","volume":"84","author":"Rose","year":"1994","journal-title":"Obstet. Gynecol."},{"issue":"9747","key":"10.1016\/j.ygyno.2015.03.047_bb0155","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(10)61268-8","article-title":"Early versus delayed treatment of relapsed ovarian cancer (MRC OV05\/EORTC 55955): a randomised trial","volume":"376","author":"Rustin","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ygyno.2015.03.047_bb0160","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/IGC.0b013e31825ad3ee","article-title":"Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?: an Italian multicentric retrospective analysis","volume":"22","author":"Carrara","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2015.03.047_bb0165","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ygyno.2013.09.008","article-title":"Post treatment surveillance of type II endometrial cancer patients","volume":"131","author":"Zakhour","year":"2013","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815007751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815007751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T20:52:23Z","timestamp":1566507143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815007751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0090825815007751"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.03.047","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns and utility of routine surveillance in high grade endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.03.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}